# Small Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/small-pharma

- Industry: Pharmaceuticals
- Headquarters: London, UK
- Website: www.smallpharma.com
- Total disclosed funding: $1M
- Latest round: Seed (Feb 22, 2017)
- Investors on record: 1

## About

Based in London, UK, and founded in 2015, Small Pharma Inc., also known as Small Pharma develops pharmaceutical products for patients suffering from severe depression. The company trades on TSXV and OTCQB under the ticker symbols DMT and DMTTF respectively. In August 2023, Cybin Inc. acquired Small Pharma Ltd. from ACF Investors. As of 2023, the company is being led by its President and CEO, Peter Rands. 

Small Pharma offers DMT (a natural compound found in plants and animals) based therapies, an alternative for traditional antidepressants to help individuals enhance their mental well-being. The company’s therapies are capable to eliminate the root cause of severe depression and provide rapid and long-lasting positive effects on individuals.

The acquisition enables Cybin Inc. to scale its intellectual property portfolio in the psychedelic drug development.

## Funding rounds

- Seed, Feb 22, 2017, $1M — ACF Investors

## Investors

- ACF Investors (https://capitalatlas.ai/funds/acf-investors) — Seed